![]() |
Name |
[4-[(Trimethylsilyl)oxy]-3-methoxyphenyl](ethoxy)acetic acid ethyl ester
|
Molecular Formula | C16H26O5Si | |
IUPAC Name* |
ethyl 2-ethoxy-2-(3-methoxy-4-trimethylsilyloxyphenyl)acetate
|
|
SMILES |
CCOC(C1=CC(=C(C=C1)O[Si](C)(C)C)OC)C(=O)OCC
|
|
InChI |
InChI=1S/C16H26O5Si/c1-7-19-15(16(17)20-8-2)12-9-10-13(14(11-12)18-3)21-22(4,5)6/h9-11,15H,7-8H2,1-6H3
|
|
InChIKey |
QDWRODCUQNALSH-UHFFFAOYSA-N
|
|
Synonyms |
1-(4-Hydroxy-3-methoxyphenyl)-1-ethoxyacetic acid, ethyl ester, TMS; Ethyl ethoxy(3-methoxy-4-[(trimethylsilyl)oxy]phenyl)acetate #; [4-[(Trimethylsilyl)oxy]-3-methoxyphenyl](ethoxy)acetic acid ethyl ester; 1-(4-Hydroxy-3-methoxyphenyl)-1-ethoxyacetic acid ethyl ester, O-trimethylsilyl
|
|
CAS | NA | |
PubChem CID | 620010 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 326.46 | ALogp: | 3.5 |
HBD: | 0 | HBA: | 5 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 54.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 22 | QED Weighted: | 0.527 |
Caco-2 Permeability: | -4.547 | MDCK Permeability: | 0.00002390 |
Pgp-inhibitor: | 0.151 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.045 |
Blood-Brain-Barrier Penetration (BBB): | 0.206 | Plasma Protein Binding (PPB): | 96.20% |
Volume Distribution (VD): | 1.554 | Fu: | 3.69% |
CYP1A2-inhibitor: | 0.848 | CYP1A2-substrate: | 0.97 |
CYP2C19-inhibitor: | 0.293 | CYP2C19-substrate: | 0.891 |
CYP2C9-inhibitor: | 0.099 | CYP2C9-substrate: | 0.686 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.643 |
CYP3A4-inhibitor: | 0.062 | CYP3A4-substrate: | 0.652 |
Clearance (CL): | 2.795 | Half-life (T1/2): | 0.245 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.023 |
Drug-inuced Liver Injury (DILI): | 0.305 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.003 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.191 | Carcinogencity: | 0.033 |
Eye Corrosion: | 0.007 | Eye Irritation: | 0.474 |
Respiratory Toxicity: | 0.1 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001182 | ![]() |
0.476 | D0VU8Q | ![]() |
0.292 | ||
ENC001363 | ![]() |
0.378 | D01JFT | ![]() |
0.292 | ||
ENC000499 | ![]() |
0.366 | D02XJY | ![]() |
0.286 | ||
ENC000478 | ![]() |
0.343 | D02LCR | ![]() |
0.283 | ||
ENC001149 | ![]() |
0.341 | D07ESC | ![]() |
0.281 | ||
ENC001123 | ![]() |
0.341 | D0U9QU | ![]() |
0.280 | ||
ENC000712 | ![]() |
0.324 | D0K2TB | ![]() |
0.278 | ||
ENC004219 | ![]() |
0.290 | D0FN7J | ![]() |
0.277 | ||
ENC000501 | ![]() |
0.290 | D00HDU | ![]() |
0.272 | ||
ENC000785 | ![]() |
0.289 | D0K3LW | ![]() |
0.267 |